EDN1 and hematoma: Consistently, patients without any hematoma growth from T1 to T2 had higher levels of ET-1 at T2 compared with those with any hematoma growth (16.70 pg/mL vs. 12.83 pg/mL, p = 0.020) (Figure 4).